ATE249231T1 - Arzneimittel, nahrungszusätze und kosmetische zubereitung enthaltend eine fettsäure und ingwer - Google Patents

Arzneimittel, nahrungszusätze und kosmetische zubereitung enthaltend eine fettsäure und ingwer

Info

Publication number
ATE249231T1
ATE249231T1 AT00907455T AT00907455T ATE249231T1 AT E249231 T1 ATE249231 T1 AT E249231T1 AT 00907455 T AT00907455 T AT 00907455T AT 00907455 T AT00907455 T AT 00907455T AT E249231 T1 ATE249231 T1 AT E249231T1
Authority
AT
Austria
Prior art keywords
ginger
fatty acid
preparations containing
cosmetic preparations
medicinal products
Prior art date
Application number
AT00907455T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Eurovita As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurovita As filed Critical Eurovita As
Application granted granted Critical
Publication of ATE249231T1 publication Critical patent/ATE249231T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00907455T 1999-03-03 2000-03-02 Arzneimittel, nahrungszusätze und kosmetische zubereitung enthaltend eine fettsäure und ingwer ATE249231T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900293 1999-03-03
PCT/DK2000/000087 WO2000051576A2 (en) 1999-03-03 2000-03-02 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain

Publications (1)

Publication Number Publication Date
ATE249231T1 true ATE249231T1 (de) 2003-09-15

Family

ID=8091922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00907455T ATE249231T1 (de) 1999-03-03 2000-03-02 Arzneimittel, nahrungszusätze und kosmetische zubereitung enthaltend eine fettsäure und ingwer

Country Status (11)

Country Link
US (2) US6482421B2 (de)
EP (1) EP1156814B1 (de)
AT (1) ATE249231T1 (de)
AU (1) AU2903300A (de)
CA (1) CA2366318A1 (de)
DE (1) DE60005152T2 (de)
DK (1) DK1156814T3 (de)
ES (1) ES2206195T3 (de)
HK (1) HK1042240B (de)
PT (1) PT1156814E (de)
WO (1) WO2000051576A2 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485752B1 (en) * 2000-10-23 2002-11-26 Otto Torbjorn Hansen Composition and method for alleviating joint pain and stiffness
US6469384B2 (en) * 2001-02-01 2002-10-22 Fairchild Semiconductor Corporation Unmolded package for a semiconductor device
US7025985B2 (en) * 2001-05-28 2006-04-11 Kanebo, Ltd. Dihydroxyphenyl compounds and glucoside compounds thereof
CA2463496A1 (en) * 2001-10-11 2003-04-17 Centro De Investigacion Y Desarrollo De Medicamentos Method of obtaining an extract of ginger
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
WO2005000332A2 (en) * 2003-06-27 2005-01-06 Astellas Pharma Inc. Therapeutic agent for soft tissue sarcoma
US8633246B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
JP2005145900A (ja) * 2003-11-17 2005-06-09 Tsumura & Co 育毛剤組成物及び痒み抑制剤
US7338674B2 (en) * 2004-12-23 2008-03-04 Council Of Scientific And Industrial Research Anti-arthritic herbal composition and method thereof
KR100588469B1 (ko) 2005-02-21 2006-11-23 한국생명공학연구원 생강에서 분리된 쇼가올을 포함하는 비만의 예방 및 치료용조성물
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
US8017162B2 (en) * 2005-10-26 2011-09-13 Oryza Oil & Fat Chemical Co., Ltd. Anti-inflammatory agent
EP1965820A4 (de) * 2005-11-16 2010-01-06 Natbio Pty Ltd Extrakt aus der zingiber-pflanze
WO2007066305A1 (en) * 2005-12-09 2007-06-14 Zelpy 2549 (Pty) Limited Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain
DE102005062145A1 (de) * 2005-12-22 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingwerextrakt zur Inhibierung humaner Arzneistofftransporter
DE102005062144A1 (de) * 2005-12-22 2007-08-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingwerfraktion zur Inhibierung humaner CYP Enzyme
GB2436063A (en) 2006-03-16 2007-09-19 Nicholas John Larkins Pharmaceutical composition for the treatment of excess mucous production
JP5207341B2 (ja) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
WO2008070783A2 (en) * 2006-12-07 2008-06-12 Herbalscience Singapore Pte. Ltd. Compositions and methods comprising zingiber species
DE102007055344A1 (de) * 2007-11-19 2009-05-20 K. D. Pharma Bexbach Gmbh Neue Verwendung von Omega-3-Fettsäure(n)
CN102118981A (zh) * 2008-06-10 2011-07-06 帝斯曼知识产权资产管理有限公司 植物提取物和pufa组合
PL2334295T3 (pl) 2008-09-02 2017-12-29 Amarin Pharmaceuticals Ltd Kompozycja farmaceutyczna zawierająca kwas eikozapentaenowy i kwas nikotynowy oraz sposoby jej zastosowania
SG10201912687WA (en) 2009-04-29 2020-02-27 Amarin Pharmaceuticals Ie Ltd Stable Pharmaceutical Composition And Methods Of Using Same
CN104042617A (zh) 2009-04-29 2014-09-17 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
EP3698781A1 (de) 2009-06-15 2020-08-26 Amarin Pharmaceuticals Ireland Limited Zusammensetzungen mit eicosapentaensäure zur behandlung von myokardinfarktionen bei patienten mit gleichzeitiger statin-therapie
CA2774542A1 (en) * 2009-09-18 2011-03-24 Phycoil Biotechnology International, Inc. Microalgae fermentation using controlled illumination
RU2758369C2 (ru) 2009-09-23 2021-10-28 Амарин Фармасьютикалз Айрлэнд Лимитед Фармацевтическая композиция, включающая омега-3 жирную кислоту и гидроксипроизводное статина, и способы ее применения
DE102009055917A1 (de) * 2009-11-27 2011-06-01 Beiersdorf Ag Verwendung von Zingeron gegen Altershaut
NZ587634A (en) * 2010-08-27 2013-10-25 Rato Health Ltd Transdermal Patch
KR101239055B1 (ko) 2010-09-03 2013-03-04 한국식품연구원 제론본 또는 이의 염을 유효성분으로 함유하는 비만예방 및 치료용 조성물
WO2012052848A1 (en) * 2010-10-21 2012-04-26 Innolipid, As Concentration of polyunsaturated fatty acids by distillation using removable isovolatile co-distilling agents
NZ744990A (en) 2010-11-29 2019-10-25 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
FR2973227B1 (fr) * 2011-04-01 2014-08-08 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
FR2973228B1 (fr) * 2011-04-01 2014-08-01 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
TWI468170B (zh) 2011-07-18 2015-01-11 Univ Kaohsiung Medical 薑化合物之用途
WO2013070735A1 (en) 2011-11-07 2013-05-16 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
KR101174701B1 (ko) * 2011-12-29 2012-08-17 서울대학교산학협력단 진저레논 에이를 포함하는 비만 예방용 식품 조성물, 비만 치료용 약학조성물 및 비만 치료용 동물용 의약품
US9827219B2 (en) 2012-01-06 2017-11-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
LT4338805T (lt) 2012-06-29 2025-09-25 Amarin Pharmaceuticals Ireland Limited Eikozapentaeno rūgšties etilo esteris, skirtas panaudoti mažinant nemirtino miokardo infarkto riziką subjektui, gydomam statinais
WO2014031087A1 (en) * 2012-08-21 2014-02-27 Agricultural Research Develpoment Agency (Public Organization) Natural synergistic formulations containing andrographis paniculata extracts for supporting the inhibition of cartilate degradation in degenerative joint disease
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
CA2935204A1 (en) * 2013-12-24 2015-07-02 Innovative Herbal Products (Aust) Pty Ltd Treatment of pain
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
CN109640931B (zh) * 2016-08-30 2021-12-28 联合利华知识产权控股有限公司 个人护理组合物
TW201900160A (zh) 2017-05-19 2019-01-01 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
EP3750535B1 (de) 2018-09-24 2025-12-31 Amarin Pharmaceuticals Ireland Limited Verfahren zur verringerung des risikos von kardiovaskulären ereignissen in einem subjekt
CN113226058A (zh) * 2019-11-11 2021-08-06 弗门尼舍有限公司 姜酚化合物及其作为风味改良剂的用途
BR112022009189A2 (pt) 2019-11-12 2022-07-26 Amarin Pharmaceuticals Ie Ltd Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure
KR102647997B1 (ko) * 2021-06-15 2024-03-18 주식회사 제넨셀 증숙생강 추출물 또는 이로부터 분리된 1-데하이드로-6-진저다이온을 유효성분으로 포함하는 퇴행성 관절염 예방, 개선, 또는 치료용 조성물
AU2024221532A1 (en) * 2023-02-15 2025-09-11 Evithe Limited Methods of preparation of zingerone, compositions comprising zingerone, and uses therefor
CN116617249B (zh) * 2023-06-16 2026-03-24 浙江省农业科学院 铁皮石斛茎/叶多糖的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01180822A (ja) * 1988-01-12 1989-07-18 Dainippon Pharmaceut Co Ltd 抗遅延型アレルギー剤
JPH07267856A (ja) * 1994-02-09 1995-10-17 Green Cross Corp:The 経口免疫抑制剤
GB9506837D0 (en) * 1995-04-03 1995-05-24 Scotia Holdings Plc Triglycerides
FR2752381B1 (fr) * 1996-08-13 1998-11-06 Pierre Moreau Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement

Also Published As

Publication number Publication date
US6482421B2 (en) 2002-11-19
US6638525B2 (en) 2003-10-28
DE60005152D1 (de) 2003-10-16
HK1042240A1 (en) 2002-08-09
DK1156814T3 (da) 2004-01-12
WO2000051576A3 (en) 2001-03-29
HK1042240B (en) 2004-05-07
PT1156814E (pt) 2004-01-30
DE60005152T2 (de) 2004-07-08
EP1156814A2 (de) 2001-11-28
AU2903300A (en) 2000-09-21
US20030035853A1 (en) 2003-02-20
WO2000051576A2 (en) 2000-09-08
ES2206195T3 (es) 2004-05-16
US20020051800A1 (en) 2002-05-02
CA2366318A1 (en) 2000-09-08
EP1156814B1 (de) 2003-09-10

Similar Documents

Publication Publication Date Title
ATE249231T1 (de) Arzneimittel, nahrungszusätze und kosmetische zubereitung enthaltend eine fettsäure und ingwer
JP6847871B2 (ja) ウロリチン類含有水溶液、その乾燥固形組成物、および、それらの製造方法、ならびにウロリチン類の安定化方法
JP6244594B2 (ja) 老化抑制剤
WO2017094905A1 (ja) 育毛・発毛促進剤
AU5079600A (en) Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine
ATE239490T1 (de) Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz
JP5224770B2 (ja) コラーゲン産生促進剤、促進方法、香粧品、飲食品および医薬品
JP2017007951A (ja) ウロリチンを含有する光老化抑制剤
JP6787633B2 (ja) ウロリチン類含有水溶液、その乾燥固形組成物、および、それらの製造方法、ならびにウロリチン類の安定化方法および水溶化方法
JP6799767B2 (ja) ウロリチン類を含有するメラニン産生抑制剤
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
DE50000168D1 (de) Orale darreichungsform
JP6948774B2 (ja) ウロリチン類を含有する前駆脂肪細胞分化抑制剤
KR101165934B1 (ko) 혈관보호제들의 합제와 그들을 함유한 제제
JP2007261946A (ja) アシルアミノ酸亜鉛塩から成る炎症抑制剤
JP2008013481A (ja) ゲットウ（Ａｌｐｉｎｉａｓｐｅｃｉｏｓａ）由来のチロシナーゼ活性阻害剤及びリポキシゲナーゼ活性阻害剤
KR101071852B1 (ko) 도코사헥사에노일 리소포스파티딜콜린을 유효성분으로 함유하는 항염증 조성물
KR101127279B1 (ko) 신규제조방법으로 제조된 흑인삼엽 및 이의 추출물을함유하는 항산화용 조성물
KR101887140B1 (ko) 열에 의한 피부 노화 예방용 조성물
JP2019182863A (ja) 肌のハリ又はうるおいの改善用組成物
EP1474998B1 (de) Zusammensetzung zur Gewichtskontrolle
KR101229438B1 (ko) 항염증 활성을 갖는 오메가-3 계열 리소포스파티딜콜린 수산화물 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 항염증 조성물
TH48498A3 (th) สารที่คล้ายแคพไซซินอยด์ชนิดใหม่ที่มีพันธะของเอสเตอร์
JP2004075558A (ja) 美白改善用キット
TH50745C3 (th) สารที่คล้ายแคพไซซินอยด์ชนิดใหม่ที่มีพันธะของเอสเตอร์

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1156814

Country of ref document: EP

REN Ceased due to non-payment of the annual fee